Robert Duggan

Positive clinical trial results for a drug candidate to treat lung cancer sent shares of this unprofitable biotech firm soaring–and turbocharged Robert Duggan’s net worth.

In an exclusive excerpt from For Blood And Money, the untold story of Wayne Rothbaum and the worst trade of his life. But what cost him some $700 million turned out to be the boon for countless cancer patients.

Stephen Schwarzman, Diane Hendricks, Steve Wynn: About 14% of America’s billionaires donated to Donald Trump’s reelection campaign, according to an analysis of records filed with the Federal Election Commission.

In August pharmaceuticals billionaire Robert Duggan said he would “do considerably more as we head towards the election.” He certainly kept his promise.

Big money donors from Bass Pro Shops, Ashley Furniture, Apollo Global Management and more donated to Trump in recent months.

Donald Trump picked up new contributions from five billionaires and one spouse of a billionaire in August.

Robert Duggan has become the executive chairman of Summit Therapeutics, a British antibiotics company.

Overall, the collective stakes of Facebook’s and Microsoft’s billionaire backers rose $7.4 billion today.

With a minimum net worth of $2 billion, it is tougher than ever to stay on the Forbes 400. Meet the 26 who dropped off this year.

The challenge was daunting: Demonstrate that you have a disruptive, scalable idea that can solve a global problem.

Forbes Announces $1 Million Global Change the World Social Entrepreneurs Competition at its Second Annual “Under 30 Summit” Partners Schusterman Family Foundation, Case Foundation, Pratt Foundation, Keywell Foundation and Bob Duggan Will Fund World’s Biggest-Ever Contest for Young Social Entrepreneurs The Wharton Social Impact Initiative of the University of Pennsylvania Will Screen [...]

Add Pharmacyclics CEO Robert Duggan to the list of billionaires who made audacious bets during the market tumult and held on to only to see staggering returns as U.S. markets roared back.

A combination of management smarts, providence and a breakthrough treatment made Robert Duggan a biotech billionaire. Long-term success? That's another story.

Winners and losers.

Analysts say that a new study of Imbruvica, one of the most promising cancer pills approved in recent years, could lead doctors to prescribe the drug to a broader population than the Food and Drug Administration has approved even before full data from it become available. Shares in maker Pharmacylics, the [...]

Scott Gilmore holds the key to Liberia's trove of entrepreneurs.